thiazoles has been researched along with mocimycin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amati, G; Cappellano, C; Donadio, S; Monti, F; Sarubbi, E; Sosio, M | 1 |
Islam, K; Landini, P; Lociuro, S; Marzorati, E; Monti, F; Soffientini, A | 1 |
Kraal, B; Möhrle, VG; Tieleman, LN | 1 |
Clough, B; Preiser, PR; Rangachari, K; Strath, M; Wilson, RJ | 1 |
Hilgenfeld, R; Hogg, T; Mesters, JR | 1 |
Anborgh, PH; Okamura, S; Parmeggiani, A | 1 |
Bibb, MJ; Olsthoorn-Tieleman, LN; Palstra, RJ; Pleij, CW; van Wezel, GP | 1 |
Brown, NE; Goldberg, JB; Prezioso, SM | 1 |
2 review(s) available for thiazoles and mocimycin
Article | Year |
---|---|
Inhibitory mechanisms of antibiotics targeting elongation factor Tu.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Macromolecular Substances; Peptide Elongation Factor Tu; Peptides, Cyclic; Polyenes; Protein Synthesis Inhibitors; Pyridones; Thiazoles | 2002 |
Elfamycins: inhibitors of elongation factor-Tu.
Topics: Actinomycetales; Actinomycetales Infections; Aminoglycosides; Anti-Bacterial Agents; Drug Design; Escherichia coli; Guanosine Triphosphate; Peptide Elongation Factor Tu; Peptides, Cyclic; Polyenes; Pyridones; Ribosomes; Thiazoles | 2017 |
6 other study(ies) available for thiazoles and mocimycin
Article | Year |
---|---|
An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea.
Topics: Actinomycetales; Amino Acid Sequence; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Carrier Proteins; Cloning, Molecular; Conserved Sequence; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Maltose-Binding Proteins; Models, Molecular; Molecular Sequence Data; Monosaccharide Transport Proteins; Mutation; Peptide Elongation Factor Tu; Peptides, Cyclic; Periplasmic Binding Proteins; Pyridones; Recombinant Fusion Proteins; Recombinant Proteins; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Thiazoles | 1996 |
Antibiotics MDL 62,879 and kirromycin bind to distinct and independent sites of elongation factor Tu (EF-Tu).
Topics: Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Chromatography, High Pressure Liquid; Models, Chemical; Peptide Elongation Factor Tu; Peptides; Peptides, Cyclic; Poly U; Pyridones; RNA, Transfer, Amino Acyl; Thiazoles | 1996 |
Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
Topics: Actinomycetales; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cell-Free System; Cloning, Molecular; Drug Resistance, Microbial; Genes, Bacterial; Kinetics; Molecular Sequence Data; Peptide Biosynthesis; Peptide Elongation Factor Tu; Peptides; Peptides, Cyclic; Protein Biosynthesis; Protein Structure, Secondary; Pyridones; Recombinant Proteins; Sequence Homology, Amino Acid; Streptomyces; Thiazoles | 1997 |
Antibiotic inhibitors of organellar protein synthesis in Plasmodium falciparum.
Topics: Animals; Anti-Bacterial Agents; Binding Sites; Genes, Protozoan; Macrocyclic Compounds; Peptide Elongation Factor Tu; Peptides, Cyclic; Plasmodium falciparum; Plastids; Polyenes; Protozoan Proteins; Pyridones; Recombinant Proteins; Thiazoles | 1999 |
Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Enzyme Inhibitors; Enzyme Stability; GTP Phosphohydrolases; Guanosine Diphosphate; Guanosine Triphosphate; Hydrolysis; Peptide Elongation Factor Tu; Peptide Elongation Factors; Peptides, Cyclic; Protein Denaturation; Pyridones; Thiazoles; Trypsin; Urea | 2004 |
Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Models, Molecular; Peptide Elongation Factor Tu; Peptides, Cyclic; Pyridones; RNA, Bacterial; RNA, Messenger; Streptomyces; Streptomyces coelicolor; Thiazoles; Transcription, Genetic | 2007 |